Q4 2020

Filed Mar 1, 2021 · 10-K · 60 days after period end · 0001564590-21-009871

Q4 2020 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$65.00M

derived+715.1% vs Q4 2019

Net Income

-$58.63M

derivedN/M vs Q4 2019

EPS, diluted—

Same quarter

Metric	Q4 2020derived from reported figures	Q4 2019derived from reported figures	Q4 2018derived from reported figures	Q4 2017derived from reported figures
Revenue	$65.00M	$7.97M	$108.05M	$30.74M
Net Income	-$58.63M	-$98.12M	$20.95M	-$33.89M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR